.
Why Epilepsy Still Needs Global Attention
Epilepsy is far from rare. The World Health Organization estimates that about 50 million people worldwide live with the condition, making it one of the most common chronic neurological disorders. In Russia the prevalence is roughly 3‑4 per 1,000 inhabitants, a figure that continues to rise as diagnostic tools improve and public awareness grows.
Despite these numbers, many still view epilepsy as a “scary” and mysterious disease. This outdated perception creates a heavy psychological burden for patients, affecting their quality of life more than the seizures themselves.
Myths that Still Persist
Other harmful myths include trying to hold the person down or performing mouth‑to‑mouth ventilation during convulsions. Both actions risk injury and do not stop the seizure, which will end on its own.
The Evolving Clinical Picture
Most people picture a dramatic tonic‑clonic seizure with loss of consciousness, yet this represents only one of more than forty possible seizure types. The clinical manifestation depends on the brain region where abnormal electrical activity originates.
Seizures can appear as brief “blank-outs,” subtle limb twitches, strange tastes or smells, visual distortions, sudden fear, or even remain fully conscious. Because of such atypical signs, diagnosis can be delayed for years.
Hidden Epilepsy and Advanced Diagnostics
When seizures are rare or subtle, patients may remain unaware of their condition. Accurate diagnosis now relies on detailed medical histories, video‑EEG monitoring (sometimes for a full day), and high‑resolution MRI performed with a specialized epileptology protocol to spot minute brain changes.
Treatment Landscape Today and Tomorrow
Modern pharmacotherapy offers strong results: around 70 % of patients achieve complete, long‑term remission with correctly chosen medication. The current strategy starts with monotherapy—using a single drug—to minimize side effects and boost adherence.
When Can Medication Be Tapered?
Life‑long drug use isn’t always required. If a patient remains seizure‑free for 2–3 years (some guidelines suggest up to 5 years
Approximately 30 % of patients develop drug‑resistant (refractory) epilepsy. In these cases, deeper diagnostics such as prolonged video‑EEG, PET scans, or stereotactic EEG pinpoint the seizure focus. If the focus is safely removable, surgical resection can be curative. When surgery isn’t an option, neuromodulation—such as vagus nerve stimulation (VNS) or deep brain stimulation (DBS)—can substantially lower seizure frequency and severity. While a single typical seizure rarely causes death, the overall mortality risk for people with epilepsy is 1.5–3 times higher than the general population. Main contributors are injuries from falls, burns, drowning, and the rare but serious sudden unexpected death in epilepsy (SUDEP). Achieving medication‑induced remission dramatically lowers SUDEP risk. Even when seizures are well‑controlled, stigma and misunderstanding often become the main obstacle to a fulfilling life. Discrimination in education, employment, and personal relationships can be more damaging than the seizures themselves. Future progress hinges on widespread education, open dialogue, and factual communication about epilepsy’s true nature—a chronic neurological disorder that, for most, can be effectively managed. If you or someone you know is living with epilepsy, share this article to help dispel myths and promote accurate first‑aid practices. Contact our clinic for a comprehensive evaluation, or subscribe to our newsletter for the latest updates on epilepsy research and care.Managing Refractory Epilepsy
Reducing Risks and Enhancing Quality of Life
First‑Aid Essentials (Pro Tip)
Societal Barriers and the Future of Stigma Reduction
Frequently Asked Questions
Take Action
Keep reading